Hemp Product Market Future Backed By McConnell, Fate Depends On Farm Bill
This article was originally published in The Rose Sheet
Executive Summary
The surprising support of Senate majority leader Mitch McConnell is integral to the success of a provision in legislation to reauthorize USDA programs that would clarify hemp's removal from the federal list of controlled substances and ease limits on its production in the US. Meanwhile, Charlotte's Web Holdings' recent $100m IPO is a strong sign of investors' confidence in the future market for hemp products.
You may also be interested in...
CBD Supplement Firms Can Lawfully Use Banks In Legislation House Passed
Secure and Fair Enforcement Act would allow businesses marketing cannabis- and hemp-containing non-drug products as well as marijuana growers and sellers to use US banks through protections for depository institutions providing financial services; Senate legislation stalled in committee.
Senate FDA Appropriation Includes $2M For CBD Enforcement Discretion Policy
FDA To Consider Regulatory Shift Making Cannabis Ingredients Officially Eligible For Use In Dietary Supplements
FDA's prohibition against using ingredients derived from the cannabis plant in supplements and food isn't lifted by the farm bill President Trump signed on Dec. 20, but the agency recognizes sales of supplement and food products containing cannabidiol and other cannabis derivatives are exploding in the US.
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests:
